160 related articles for article (PubMed ID: 9663893)
1. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis.
Linden T; Forsbäck G; Deppisch R; Henle T; Wieslander A
Perit Dial Int; 1998; 18(3):290-3. PubMed ID: 9663893
[TBL] [Abstract][Full Text] [Related]
2. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.
Schalkwijk CG; Posthuma N; ten Brink HJ; ter Wee PM; Teerlink T
Perit Dial Int; 1999; 19(4):325-33. PubMed ID: 10507813
[TBL] [Abstract][Full Text] [Related]
3. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
4. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids.
Wieslander A; Linden T; Musi B; Carlsson O; Deppisch R
Perit Dial Int; 2000; 20 Suppl 5():S23-7. PubMed ID: 11229608
[TBL] [Abstract][Full Text] [Related]
5. PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization.
Erixon M; Lindén T; Kjellstrand P; Carlsson O; Ernebrant M; Forsbäck G; Wieslander A; Jönsson JA
Perit Dial Int; 2004; 24(4):392-8. PubMed ID: 15335155
[TBL] [Abstract][Full Text] [Related]
6. Degradation in peritoneal dialysis fluids may be avoided by using low pH and high glucose concentration.
Kjellstrand P; Martinson E; Wieslander A; Kjellstrand K; Jeppsson E; Svensson E; Järkelid L; Linden T; Olsson LF
Perit Dial Int; 2001; 21(4):338-44. PubMed ID: 11587395
[TBL] [Abstract][Full Text] [Related]
7. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids.
Distler L; Georgieva A; Kenkel I; Huppert J; Pischetsrieder M
Chem Res Toxicol; 2014 Aug; 27(8):1421-30. PubMed ID: 25033248
[TBL] [Abstract][Full Text] [Related]
8. Take care in how you store your PD fluids: actual temperature determines the balance between reactive and non-reactive GDPs.
Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
Perit Dial Int; 2005; 25(6):583-90. PubMed ID: 16411526
[TBL] [Abstract][Full Text] [Related]
9. Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis.
Tauer A; Bender TO; Fleischmann EH; Niwa T; Jörres A; Pischetsrieder M
Mol Nutr Food Res; 2005 Jul; 49(7):710-5. PubMed ID: 15915443
[TBL] [Abstract][Full Text] [Related]
10. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
[TBL] [Abstract][Full Text] [Related]
11. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
Zeier M; Schwenger V; Deppisch R; Haug U; Weigel K; Bahner U; Wanner C; Schneider H; Henle T; Ritz E
Kidney Int; 2003 Jan; 63(1):298-305. PubMed ID: 12472796
[TBL] [Abstract][Full Text] [Related]
12. 3,4-DGE in peritoneal dialysis fluids cannot be found in plasma after infusion into the peritoneal cavity.
Erixon M; Wieslander A; Lindén T; Carlsson O; Jönsson JA; Simonsen O; Kjellstrand P
Perit Dial Int; 2008; 28(3):277-82. PubMed ID: 18474921
[TBL] [Abstract][Full Text] [Related]
13. Temperature: the single most important factor for degradation of glucose fluids during storage.
Kjellstrand P; Erixon M; Wieslander A; Lindén T; Martinson E
Perit Dial Int; 2004; 24(4):385-91. PubMed ID: 15335154
[TBL] [Abstract][Full Text] [Related]
14. Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content.
Schmitt CP; von Heyl D; Rieger S; Arbeiter K; Bonzel KE; Fischbach M; Misselwitz J; Pieper AK; Schaefer F;
Nephrol Dial Transplant; 2007 Jul; 22(7):2038-44. PubMed ID: 17420168
[TBL] [Abstract][Full Text] [Related]
15. 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids infused into the peritoneal cavity cannot be found in plasma.
Erixon M; Wieslander A; Lindén T; Carlsson O; Jönsson JA; Simonsen O; Kjellstrand P
Perit Dial Int; 2009 Feb; 29 Suppl 2():S28-31. PubMed ID: 19270226
[TBL] [Abstract][Full Text] [Related]
16. How to avoid glucose degradation products in peritoneal dialysis fluids.
Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
Perit Dial Int; 2006; 26(4):490-7. PubMed ID: 16881345
[TBL] [Abstract][Full Text] [Related]
17. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes.
Nilsson-Thorell CB; Muscalu N; Andrén AH; Kjellstrand PT; Wieslander AP
Perit Dial Int; 1993; 13(3):208-13. PubMed ID: 8369351
[TBL] [Abstract][Full Text] [Related]
18. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response.
Welten AG; Schalkwijk CG; ter Wee PM; Meijer S; van den Born J; Beelen RJ
Perit Dial Int; 2003; 23(3):213-21. PubMed ID: 12938820
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation.
Millar DJ; Holmes C; Faict D; Dawnay A
Adv Perit Dial; 1998; 14():191-4. PubMed ID: 10649722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]